| 1 |
34375677 | Efficacy evaluation of PCSK9 monoclonal antibody (Evolocumab) in combination with Rosuvastatin and Ezetimibe on cholesterol levels in patients with coronary heart disease (CHD): A retrospective analysis from a single center in China. | 2022 Apr |
4 |
| 2 |
34307425 | Breaking Therapeutic Inertia With Alirocumab in an 80-Year-Old Patient With Severe Hypercholesterolemia: A Case Report. | 2021 |
1 |
| 3 |
32003938 | A randomized, double-blind clinical trial to evaluate the efficacy and safety of a fixed-dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and hypertension. | 2020 Feb |
3 |
| 4 |
28836458 | Efficacy and safety of rosuvastatin versus atorvastatin in high-risk Chinese patients with hypercholesterolemia: a randomized, double-blind, active-controlled study. | 2018 Feb |
4 |
| 5 |
29476887 | Trends and disparities in statin use and low-density lipoprotein cholesterol levels among US patients with diabetes, 1999-2014. | 2018 May |
1 |
| 6 |
29524865 | Is the lower risk of venous thromboembolism with statins related to low-density-lipoprotein reduction? A network meta-analysis and meta-regression of randomised controlled trials. | 2018 Apr |
1 |
| 7 |
29857919 | Efficacy and Safety of Ezetimibe and Rosuvastatin Combination Therapy Versus Those of Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia. | 2018 Jun |
2 |
| 8 |
27798317 | Clinical Pharmacist Patient-Safety Initiative to Reduce Against-Label Prescribing of Statins With Cyclosporine. | 2017 Feb |
1 |
| 9 |
28429691 | Comparison of the effects of high-dose atorvastatin and high-dose rosuvastatin on oxidative stress in patients with acute myocardial infarction: A pilot study. | 2017 Apr |
1 |
| 10 |
28599257 | Effectiveness of adherence to lipid lowering therapy on LDL-cholesterol in patients with very high cardiovascular risk: A real-world evidence study in primary care. | 2017 Aug |
1 |
| 11 |
28807393 | Treatment Trends, Effectiveness, and Safety of Statins on Lipid Goal Attainment in Chinese Percutaneous Coronary Intervention Patients: a Multicenter, Retrospective Cohort Study. | 2017 Sep |
3 |
| 12 |
28848611 | Effects of Different Types of Statins on Lipid Profile: A Perspective on Asians. | 2017 Apr |
2 |
| 13 |
29201198 | Comparison of the effect of rosuvastatin versus rosuvastatin/ezetimibe on markers of inflammation in patients with acute myocardial infarction. | 2017 Nov |
2 |
| 14 |
29255347 | Pharmacokinetic and pharmacodynamic interaction between ezetimibe and rosuvastatin in healthy male subjects. | 2017 |
1 |
| 15 |
26589368 | Switching from atorvastatin to rosuvastatin lowers small, dense low-density lipoprotein cholesterol levels in Japanese hypercholesterolemic patients with type 2 diabetes mellitus. | 2016 Jan |
1 |
| 16 |
26638010 | Efficacy and safety of adding alirocumab to rosuvastatin versus adding ezetimibe or doubling the rosuvastatin dose in high cardiovascular-risk patients: The ODYSSEY OPTIONS II randomized trial. | 2016 Jan |
5 |
| 17 |
26969416 | A VOYAGER Meta-Analysis of the Impact of Statin Therapy on Low-Density Lipoprotein Cholesterol and Triglyceride Levels in Patients With Hypertriglyceridemia. | 2016 May 1 |
1 |
| 18 |
27105046 | Intensive statin therapy stabilizes C-reactive protein, but not chemokine in stable coronary artery disease treated with an everolimus-eluting stent. | 2016 Aug |
1 |
| 19 |
25626487 | Impact of Switching From High-Efficacy Lipid-Lowering Therapies to Generic Simvastatin on LDL-C Levels and LDL-C Goal Attainment Among High-Risk Primary and Secondary Prevention Populations in the United Kingdom. | 2015 Apr 1 |
3 |
| 20 |
25864881 | Clinical evaluation of rosuvastatin in heart transplant patients with hypercholesterolemia and therapeutic failure of other statin regimens: short-term and long-term efficacy and safety results. | 2015 Sep |
1 |
| 21 |
25971444 | The difference between Asian and Western in the effect of LDL-C lowering therapy on coronary atherosclerotic plaque: a meta-analysis report. | 2015 Feb 14 |
2 |
| 22 |
26074319 | To what extent do high-intensity statins reduce low-density lipoprotein cholesterol in each of the four statin benefit groups identified by the 2013 American College of Cardiology/American Heart Association guidelines? A VOYAGER meta-analysis. | 2015 Aug |
1 |
| 23 |
26365713 | Achievement of specified lipid and high-sensitivity C-reactive protein levels with two statins in Chinese patients with hypercholesterolaemia. | 2015 Sep 13 |
3 |
| 24 |
26687694 | Efficacy and safety of rosuvastatin therapy in children and adolescents with familial hypercholesterolemia: Results from the CHARON study. | 2015 Nov-Dec |
1 |
| 25 |
26721008 | EFFICACY OF 5 MG AND 10 MG ROSUVASTATIN IN TYPE-2 DIABETES MELLITUS WITH HYPERCHOLESTEROALEMIA. | 2015 Jul-Sep |
3 |
| 26 |
24456217 | Achievement rates of Japan Atherosclerosis Society Guidelines 2007 LDL-cholesterol goals with rosuvastatin or atorvastatin in patients who had not achieved their goal with atorvastatin. | 2014 Jun |
2 |
| 27 |
24632963 | Change in carotid intima-media thickness in a high-risk group of patients by intensive lipid-lowering therapy with rosuvastatin: subanalysis of the JART study. | 2014 |
2 |
| 28 |
24734885 | Population pharmacodynamic analysis of LDL-cholesterol lowering effects by statins and co-medications based on electronic medical records. | 2014 Oct |
1 |
| 29 |
24800084 | Comparison of low-dose rosuvastatin with atorvastatin in lipid-lowering efficacy and safety in a high-risk pakistani cohort: an open-label randomized trial. | 2014 |
2 |
| 30 |
24886532 | Systematic study of the effects of lowering low-density lipoprotein-cholesterol on regression of coronary atherosclerotic plaques using intravascular ultrasound. | 2014 May 2 |
3 |
| 31 |
25022285 | Early decrease in carotid plaque lipid content as assessed by magnetic resonance imaging during treatment of rosuvastatin. | 2014 Jul 14 |
2 |
| 32 |
25262434 | Effect of a hydrophilic and a hydrophobic statin on cardiac salvage after ST-elevated acute myocardial infarction - a pilot study. | 2014 Nov |
3 |
| 33 |
25463129 | Achieving goal lipid levels with ezetimibe plus statin add-on or switch therapy compared with doubling the statin dose. A pooled analysis. | 2014 Dec |
2 |
| 34 |
23288881 | A comparison of efficacy and safety of an ezetimibe/simvastatin combination compared with other intensified lipid-lowering treatment strategies in diabetic patients with symptomatic cardiovascular disease. | 2013 May |
1 |
| 35 |
23442255 | Effect of rosuvastatin and sevelamer on the progression of coronary artery calcification in chronic kidney disease: a pilot study. | 2013 Jul |
2 |
| 36 |
23644489 | Achievement of LDL-C goals depends on baseline LDL-C and choice and dose of statin: an analysis from the VOYAGER database. | 2013 Dec |
4 |
| 37 |
24265554 | Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy. | 2013 |
5 |
| 38 |
21782402 | Prevalence of low LDL-cholesterol levels and elevated high-sensitivity C-reactive protein levels in apparently healthy Korean adults. | 2012 Dec |
2 |
| 39 |
22065156 | Rosuvastatin, proprotein convertase subtilisin/kexin type 9 concentrations, and LDL cholesterol response: the JUPITER trial. | 2012 Jan |
2 |
| 40 |
22230323 | Pharmacogenetic determinants of statin-induced reductions in C-reactive protein. | 2012 Feb 1 |
2 |
| 41 |
22331829 | Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial. | 2012 Apr 1 |
5 |
| 42 |
22534644 | The farnesoid X receptor -1G>T polymorphism influences the lipid response to rosuvastatin. | 2012 Jul |
4 |
| 43 |
22668755 | Intronic variants in SLCO1B1 related to statin-induced myopathy are associated with the low-density lipoprotein cholesterol response to statins in Chinese patients with hyperlipidaemia. | 2012 Nov |
2 |
| 44 |
22705128 | Comparison of the effects of different statins and doses on lipid levels in patients with diabetes: results from VOYAGER. | 2012 Sep |
2 |
| 45 |
20971747 | Rosuvastatin for primary prevention in patients with European systematic coronary risk evaluation risk ≥ 5% or Framingham risk >20%: post hoc analyses of the JUPITER trial requested by European health authorities. | 2011 Jan |
1 |
| 46 |
21189273 | Comparative Effectiveness and Toxicity of Statins Among HIV-Infected Patients. | 2011 Feb 1 |
3 |
| 47 |
21349260 | Switching from statin monotherapy to ezetimibe/simvastatin or rosuvastatin modifies the relationships between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients at high risk of coronary disease. | 2011 Jun |
3 |
| 48 |
21492764 | Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cholesterol <50 mg/dl with rosuvastatin. The JUPITER trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin). | 2011 Apr 19 |
4 |
| 49 |
21559521 | Clinical use and effectiveness of lipid lowering therapies in diabetes mellitus--an observational study from the Swedish National Diabetes Register. | 2011 Apr 29 |
2 |
| 50 |
21921413 | Effects of lipid-lowering therapy with rosuvastatin on kidney function and oxidative stress in patients with diabetic nephropathy. | 2011 |
1 |